ETORICOXIB (100 mg) (5-Chloro-6'-methyl-3-[4-(methylsulfonyl)phenyl]-2,3'-bipyridine )

ETORICOXIB (100 mg) (5-Chloro-6′-methyl-3-[4-(methylsulfonyl)phenyl]-2,3′-bipyridine )

In Stock

Ready to ship

Catalogue No.

1800404

CAS No.

202409-33-4

Molecular Formula

C₁₈H₁₅ClN₂O₂S

Product Type

Pharmaceutical Analytical Impurities

$430.00

Shipping information

Click Here to learn more about Pharmaceutical Analytical Impurities (PAI). PAI products are different from official USP Reference Standards. This material is an Analytical Material and not a USP Reference Standard.

Additional information

Additional information

Current Lot Information

Current Lot:

F277R0

CAS RN®

202409-33-4

Harmonized System (HS) Code *:

29333990

UN No:

N/A

NDC No:

N/A

Molecular Formula

C₁₈H₁₅ClN₂O₂S

Container Type:

VIAL

Base Control Substance (substance %):

N | A

Product Information

SDS:

USP Certificates/Product Information Sheets and Valid Use Dates

Lot No	USP Certificates/Product Information Sheets and Valid Use Dates	Valid Use Date	Country of Origin*	Material Origin*
F277R0	1800404-F277R0	See Product Information Sheet	India	Chemical Synthesis


Lot No F277R0	USP Certificates/Product Information Sheets and Valid Use Dates 1800404-F277R0
Valid Use Date See Product Information Sheet
Country of Origin* India
Material Origin* Chemical Synthesis

Lot No

F277R0

USP Certificates/Product Information Sheets and Valid Use Dates

1800404-F277R0

Valid Use Date

See Product Information Sheet

Country of Origin*

India

Material Origin*

Chemical Synthesis

Frequently bought together

ETORICOXIB (100 mg) (5-Chloro-6'-methyl-3-[4-(methylsulfonyl)phenyl]-2,3'-bipyridine )

Catalogue No.

1800404

CAS No.

202409-33-4

Molecular Formula

C₁₈H₁₅ClN₂O₂S

Product Type

Pharmaceutical Analytical Impurities

$430.00

DIDEHYDROGLYCOPYRROLATE

Catalogue No.

1A10070

CAS No.

Molecular Formula

C₁₉H₂₆BrNO₃

Product Type

Pharmaceutical Analytical Impurities

$512.50

DICLOFENAC ALCOHOL

Catalogue No.

1A10000

CAS No.

27204-57-5

Molecular Formula

C₁₃H₁₁Cl₂NO

Product Type

Pharmaceutical Analytical Impurities

$950.00

Got any Queries?

We value your curiosity and strive to provide you with all the information you need. If you have any questions or need further details about our products/services, company, or any other topic related to our website, feel free to reach out to us. Our team is here to assist you promptly.

TOFACITINIB DIMER (25 mg) (1,3-Bis{(3R,4R)-4-methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]-1-piperidinyl}-1,3-propanedione)

ETORICOXIB (100 mg) (5-Chloro-6'-methyl-3-[4-(methylsulfonyl)phenyl]-2,3'-bipyridine )

OLAPARIB DIMER (25 mg) (4,4'-{[(Piperazine-1,4-dicarbonyl)bis(4-fluoro-3,1-phenylene)]bis(methylene)}bis(phthalazin-1(2H)-one))

RANOLAZINE 1N-OXIDE (25 mg) (1-(2-((2,6-Dimethylphenyl)amino)-2-oxoethyl)-4-(2-hydroxy-3-(2-methoxyphenoxy)propyl)piperazine 1-oxide)

CINACALCET ACID

LINAGLIPTIN 3-METHYL PHTHALIMIDE

TENOFOVIR ENANTIOMER (25 mg) ((S)-(1-(6-Amino-9H-purin-9-yl)propan-2-yloxy)methylphosphonic acid)

N,N-DIDESETHYL SUNITINIB HYDROCHLORIDE (25 mg) (N-(2-Aminoethyl)-5-[(Z)-(5-fluoro-2-oxo-1,2-dihydro-3H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide hydrochloride (1:1))

LENVATINIB ACID (25 mg) (4-(3-Chloro-4-(3-cyclopropylureido)phenoxy)-7-methoxyquinoline-6-carboxylic acid)